Insider Selling: Kewaunee Scientific (NASDAQ:KEQU) VP Sells $297,216.00 in Stock

Kewaunee Scientific Corporation (NASDAQ:KEQU) VP Elizabeth Phillips sold 6,880 shares of the business’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $43.20, for a total transaction of $297,216.00. Following the sale, the vice president owned 8,248 shares of the company’s stock, valued at $356,313.60. This represents a 45.48% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Kewaunee Scientific Stock Down 1.0%

KEQU stock opened at $42.86 on Friday. The company has a fifty day moving average price of $51.64 and a 200 day moving average price of $45.21. Kewaunee Scientific Corporation has a 12 month low of $30.33 and a 12 month high of $71.33. The company has a market cap of $123.01 million, a price-to-earnings ratio of 10.38 and a beta of 0.68. The company has a debt-to-equity ratio of 0.88, a current ratio of 2.32 and a quick ratio of 1.63.

Kewaunee Scientific (NASDAQ:KEQU) last released its quarterly earnings results on Wednesday, September 10th. The technology company reported $1.10 EPS for the quarter. Kewaunee Scientific had a net margin of 4.68% and a return on equity of 25.65%. The firm had revenue of $71.10 million during the quarter.

Hedge Funds Weigh In On Kewaunee Scientific

A number of large investors have recently bought and sold shares of KEQU. Bank of America Corp DE raised its position in Kewaunee Scientific by 2,605.9% during the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock worth $28,000 after buying an additional 443 shares during the last quarter. Ritholtz Wealth Management grew its stake in shares of Kewaunee Scientific by 42.2% during the 1st quarter. Ritholtz Wealth Management now owns 17,949 shares of the technology company’s stock worth $707,000 after purchasing an additional 5,330 shares during the period. IFP Advisors Inc grew its stake in shares of Kewaunee Scientific by 61.5% during the 1st quarter. IFP Advisors Inc now owns 945 shares of the technology company’s stock worth $37,000 after purchasing an additional 360 shares during the period. American Century Companies Inc. grew its stake in shares of Kewaunee Scientific by 43.4% during the 1st quarter. American Century Companies Inc. now owns 49,182 shares of the technology company’s stock worth $1,937,000 after purchasing an additional 14,889 shares during the period. Finally, OMERS ADMINISTRATION Corp acquired a new position in shares of Kewaunee Scientific during the 1st quarter worth $284,000. Hedge funds and other institutional investors own 32.69% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently commented on KEQU. Wall Street Zen upgraded shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a research report on Saturday, July 5th. Weiss Ratings restated a “hold (c+)” rating on shares of Kewaunee Scientific in a research report on Saturday, September 27th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Kewaunee Scientific has an average rating of “Hold”.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.